ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 947 filers reported holding ASTRAZENECA PLC in Q3 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,352 | +26.2% | 1,600 | +33.3% | 0.03% | +34.8% |
| Q2 2023 | $85,884 | +3.1% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $83,292 | +2.4% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $81,360 | -99.9% | 1,200 | 0.0% | 0.02% | +4.5% |
| Q3 2022 | $65,808,000 | -71.3% | 1,200 | -65.3% | 0.02% | -63.3% |
| Q1 2022 | $229,138,000 | +13.9% | 3,454 | 0.0% | 0.06% | +20.0% |
| Q4 2021 | $201,195,000 | -15.3% | 3,454 | -12.6% | 0.05% | -23.1% |
| Q3 2021 | $237,477,000 | +356.5% | 3,954 | +464.9% | 0.06% | +828.6% |
| Q2 2014 | $52,017,000 | +14.5% | 700 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $45,416,000 | -15.0% | 700 | -22.2% | 0.01% | -25.0% |
| Q4 2013 | $53,433,000 | +14.3% | 900 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $46,737,000 | -57.0% | 900 | -60.9% | 0.01% | -57.9% |
| Q2 2013 | $108,790,000 | – | 2,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |